Horan Securities, Inc. Penumbra Inc Transaction History

Horan Securities, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$271.54 - $344.06 $13,577 - $17,203	-50 Reduced 16.67%	250 $86,000
Q4 2021 Feb 09, 2022	SELL	$238.08 - $288.0 $32,616 - $39,456	-137 Reduced 31.35%	300 $86,000
Q2 2021 Aug 05, 2021	SELL	$235.0 - $310.7 $27,730 - $36,662	-118 Reduced 21.26%	437 $120,000
Q1 2021 May 14, 2021	BUY	$175.6 - $291.43 $14,399 - $23,897	82 Added 17.34%	555 $150,000
Q4 2020 Feb 05, 2021	BUY	$174.98 - $272.83 $38,320 - $59,749	219 Added 86.22%	473 $83,000
Q3 2020 Nov 04, 2020	SELL	$185.27 - $238.73 $12,227 - $15,756	-66 Reduced 20.63%	254 $49,000
Q1 2020 May 05, 2020	BUY	$124.34 - $193.76 $39,788 - $62,003	320 New	320 $52,000
Q4 2019 Feb 05, 2020	SELL	$134.81 - $177.8 $33,702 - $44,450	-250 Closed	0 $0
Q2 2018 Jul 23, 2018	SELL	$112.2 - $165.95 $13,464 - $19,914	-120 Reduced 32.43%	250 $35,000
Q1 2018 Apr 16, 2018	BUY	$84.6 - $126.1 $31,301 - $46,657	370 New	370 $45,000

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.